Evaluation of TransFix® Mediated Stabilisation of Adipose-Derived Stromal Vascular Fraction for Delayed Flow Cytometry Analysis


The increasing implementation of multicentre studies has led to a need for the optimization of a method that allows for accurate post-hoc analysis of patient biological samples. Assessment of total cell number, viability and immunophenotype can present logistical challenges which can be aided by batch processing. The increased sample storage time that this requires necessitates the use of reagents to preserve cellular integrity, viability and immunophenotype. TransFix is a stabilising reagent that has been developed for the preservation of cell numbers and cell marker expression in peripheral whole blood for up to ten days. This study investigated the use of TransFix reagent for the preservation of the stromal vascular fraction (SVF) of collagenase digested adipose tissue. It was demonstrated that TransFix was suitable for accurately measuring nucleated SVF cell numbers for up to seven days as well as back calculating original cell viability. It also stabilised three CD markers commonly used to identify populations within SVF (CD90, CD31 and CD45) for up to seven days. There was no significant difference between the number of CD90, CD31 and CD45 positive cells after stabilisation at Day 7 compared to Day 0 unstabilised samples. The results suggest that TransFix can be used to preserve a biological mixed cell population from human adipose-derived SVF for up to seven days for accurate post-hoc analysis.

Share and Cite:

Karsten, E. , Sung, J. , Morgan, C. , Herbert, B. and Vesey, G. (2014) Evaluation of TransFix® Mediated Stabilisation of Adipose-Derived Stromal Vascular Fraction for Delayed Flow Cytometry Analysis. Open Journal of Regenerative Medicine, 3, 54-63. doi: 10.4236/ojrm.2014.33007.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Herrmann, R., Sturm, M., Shaw, K., Purtill, D., Cooney, J., Wright, M., et al. (2102) Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute and Chronic Graft versus Host Disease: A Phase 1 Study. International Journal of Hematology, 95, 182-188. http://dx.doi.org/10.1007/s12185-011-0989-2
[2] Oh, J.Y., Kim, M.K., Shin, M.S., Lee, H.J., Ko, J.H., Wee, W.R., et al. (2008) The Anti-Inflammatory and Anti-Angiogenic Role of Mesenchymal Stem Cells in Corneal Wound Healing Following Chemical Injury. Stem Cells, 26, 1047-1055. http://dx.doi.org/10.1634/stemcells.2007-0737
[3] Varma, M.J.O., Breuls, R.G., Schouten, T.E., Jurgens, W.J., Bontkes, H.J., Schuurhuis, G.J., et al. (2007) Phenotypical and Functional Characterization of Freshly Isolated Adipose Tissue-Derived Stem Cells. Stem Cells and Development, 16, 91-104. http://dx.doi.org/10.1089/scd.2006.0026
[4] De Ugarte, D., Morizono, K., Elbarbary, A., Alfonso, Z., Zuk, P., Zhu, M., et al. (2003) Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow. Cells, Tissues, Organs, 174, 101-109.
[5] Riordan, N.H., Ichim, T.E., Min, W.P., Wang, H., Solano, F., Lara, F., et al. (2009) Non-Expanded Adipose Stromal Vascular Fraction Cell Therapy for Multiple Sclerosis. Journal of Translational Medicine, 7, 29.
[6] Zimmerlin, L., Rubin, J.P., Pfeifer, M.E., Moore, L.R., Donnenberg, V.S. and Donnenberg, A.D. (2013) Human Adipose Stromal Vascular Cell Delivery in a Fibrin Spray. Cytotherapy, 15, 102-108.
[7] Premaratne, G.U., Ma, L.P., Fujita, M., Lin, X., Bollano, E. and Fu, M. (2011) Stromal Vascular Fraction Transplantation as an Alternative Therapy for Ischemic Heart Failure: Anti-Inflammatory Role. Journal of Cardiothoracic Surgery, 6, 43. http://dx.doi.org/10.1186/1749-8090-6-43
[8] Olson, W.C., Smolkin, M.E., Farris, E.M., Fink, R.J., Czarkowski, A.R., Fink, J.H., et al. (2011) Shipping Blood to a Central Laboratory in Multicenter Clinical Trials: Affect of Ambient Temperature on Specimen Temperature, and Effects of Temperature on Mononuclear Cell Yield, Viability and Immunologic Function. Journal of Translational Medicine, 9, 26. http://dx.doi.org/10.1186/1479-5876-9-26
[9] Canonico, B., Zamai, L., Burattini, S., Granger, V., Mannello, F., Gobbi, P., et al. (2004) Evaluation of Leukocyte Stabilisation in TransFix-Treated Blood Samples by Flow Cytometry and Transmission Electron Microscopy. Journal of Immunological Methods, 295, 67-78. http://dx.doi.org/10.1016/j.jim.2004.09.013
[10] Jani, V., Janossy, G., Iqbal, A., Mhalu, F., Lyamuya, E., Biberfeld, G., et al. (2001) Affordable CD4+ T Cell Counts by Flow Cytometry. II. The Use of Fixed Whole Blood in Resource-Poor Settings. Journal of Immunological Methods, 257, 145-154. http://dx.doi.org/10.1016/S0022-1759(01)00458-6
[11] Barnett, D., Granger, V., Pockley, A., Saxton, J., Storie, I., Whitby, L., et al. (1999) TransFix: A Clinical Sample Stabilising Fluid for Use in Cellular Haematology and Immunology. Cytometry, 38, 88.
[12] Ng, A.A., Lee, B.T., Teo, T.S., Poidinger, M. and Connolly, J.E. (2012) Optimal Cellular Preservation for High Dimensional Flow Cytometric Analysis of Multicentre Trials. Journal of Immunological Methods, 385, 79-89.
[13] Blaber, S.P., Webster, R.A., Hill, C.J., Breen, E.J., Kuah, D., Vesey, G. and Herbert, B.R. (2012) Analysis of in Vitro Secretion Profiles from Adipose-Derived Cell Populations. Journal of Translational Medicine, 10, 172.
[14] Sasaki, D.T., Dumas, S.E. and Engleman, E.G. (1987) Discrimination of Viable and Non-Viable Cells Using Propidium Iodide in Two Color Immunofluorescence. Cytometry, 8, 413-420.
[15] Oldaker, T.A. (2007) Quality Control in Clinical Flow Cytometry. Clinics in Laboratory Medicine, 27, 671-685.
[16] Field, J., Gougeon, R. and Marliss, E.B. (1991) Changes in Circulating Leukocytes and Mitogen Responses during Very-Low-Energy All-Protein Reducing Diets. American Journal of Clinical Nutrition, 54, 123-129.
[17] Kondo, T., Hayashi, M., Takeshita, K., Numaguchi, Y., Kobayashi, K., Iino, S., Inden, Y. and Murohara, T. (2004) Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1442-1447.
[18] Potter, C.G., Potter, A.C., Hatton, C.S., Chapel, H.M., Anderson, M.J., Pattison, J.R., et al. (1987) Variation of Erythroid and Myeloid Precursors in the Marrow and Peripheral Blood of Volunteer Subjects Infected with Human Parvovirus (B19). Journal of Clinical Investigation, 79, 1486-1492. http://dx.doi.org/10.1172/JCI112978
[19] Ashmore, L.M., Shopp, G.M. and Edwards, B.S. (1989) Lymphocyte Subset Analysis by Flow Cytometry Comparison of Three Different Staining Techniques and Effects of Blood Storage. Journal of Immunological Methods, 118, 209-215. http://dx.doi.org/10.1016/0022-1759(89)90008-2
[20] Garraud, O. and Moreau, T. (1984) Effect of Blood Storage on Lymphocyte Subpopulations. Journal of Immunological Methods, 75, 95-98. http://dx.doi.org/10.1016/0022-1759(84)90228-X
[21] McKenna, K.C., Beatty, K.M., Vicetti, M.R. and Bilonick, R.A. (2009) Delayed Processing of Blood Increases the Frequency of Activated CD11b+ CD15+ Granulocytes Which Inhibit T Cell Function. Journal of Immunological Methods, 341, 68-75. http://dx.doi.org/10.1016/j.jim.2008.10.019

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.